Substance Abuse: Research and Treatment 2013:7 1-12
Review
Published on 31 Jan 2013
DOI: 10.4137/SART.S9345
Sign up for email alerts to receive notifications of new articles published in Substance Abuse: Research and Treatment
Acamprosate (calcium acetylhomotaurine) is an amino acid modulator that has displayed efficacy in some clinical trials in reducing craving and promoting abstinence in alcohol dependent patients following detoxification. While acamprosate is safe and generally well-tolerated, not all studies have demonstrated clinical efficacy that is superior to placebo. In addition, the precise neurochemical mechanisms of action of acamprosate have still not yet been identified. In this review, we summarize current clinical data on the safety, efficacy, and pharmacokinetic properties of acamprosate, as well theories on its potential mechanism of action. We also discuss tolerability and patient preference issues and conclude with a discussion of the place of acamprosate in addiction medicine and therapy.
PDF (551.17 KB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
PMC HTML
I very much enjoyed the experience of publishing with Substance Abuse: Research and Treatment. The editorial and review staff were very helpful and understanding throughout, even when a very large and complex project was being undertaken, and a range of subjects had to be reviewed. The editor was sympathetic and understanding of the author's responses, and this combined and coordinated interplay has allowed major conceptual advances to be made with major implications for the improvement ...
Facebook Google+ Twitter
Pinterest Tumblr YouTube